|
|
Blood, 15 October 2007, Vol. 110, No. 8, pp. 2983-2990.
Prepublished online as a Blood First Edition Paper on July 20, 2007; DOI 10.1182/blood-2007-06-094656.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Induction of FOXP3 expression in naive human CD4+FOXP3– T cells by T-cell receptor stimulation is transforming growth factor-ß–dependent but does not confer a regulatory phenotype
Dat Q. Tran1,
Heather Ramsey1, and
Ethan M. Shevach1
1 Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD
Thymic-derived natural T-regulatory cells (nTregs) are important for the induction of self-tolerance and the control of autoimmunity. Murine CD4+CD25–Foxp3– cells can be induced to express Foxp3 after T-cell receptor (TCR) activation in the presence of transforming growth factor ß (TGFß) and are phenotypically similar to nTregs. Some studies have suggested that TCR stimulation of human CD4+CD25– cells results in the induction of transient expression of FOXP3, but that the induced cells lack a regulatory phenotype. We demonstrate here that TCR stimulation alone was insufficient to induce FOXP3 expression in the absence of TGFß, whereas high levels of FOXP3 expression could be induced in the presence of TGFß. Although FOXP3 expression was stable, the TGFß-induced FOXP3+ T cells were neither anergic nor suppressive and produced high levels of effector cytokines. These results suggest that even high levels of FOXP3 expression are insufficient to define a human CD4+ T cell as a T-regulatory cell.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Articles in Blood Online:
-
Defense of the clone: antibody 259D effectively labels human FOXP3 in a variety of applications
- Bridget C. Fox, Paola A. Bignone, Philip J. Brown, and Alison H. Banham
Blood 2008 111: 3897-3899.
[Full Text]
[PDF]
-
Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity
- Vinodh Pillai and Nitin J. Karandikar
Blood 2008 111: 463-464.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
B. Kavanagh, S. O'Brien, D. Lee, Y. Hou, V. Weinberg, B. Rini, J. P. Allison, E. J. Small, and L. Fong
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
Blood,
August 15, 2008;
112(4):
1175 - 1183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Yolcu, X. Gu, C. Lacelle, H. Zhao, L. Bandura-Morgan, N. Askenasy, and H. Shirwan
Induction of Tolerance to Cardiac Allografts Using Donor Splenocytes Engineered to Display on Their Surface an Exogenous Fas Ligand Protein
J. Immunol.,
July 15, 2008;
181(2):
931 - 939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Scotta, M. Soligo, C. Camperio, and E. Piccolella
FOXP3 Induced by CD28/B7 Interaction Regulates CD25 and Anergic Phenotype in Human CD4+CD25- T Lymphocytes
J. Immunol.,
July 15, 2008;
181(2):
1025 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nagar, H. Vernitsky, Y. Cohen, D. Dominissini, Y. Berkun, G. Rechavi, N. Amariglio, and I. Goldstein
Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells
Int. Immunol.,
July 9, 2008;
(2008)
dxn062v2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Serra, S. Nuti, S. Tavarini, C. Sammicheli, D. Rosa, G. Saletti, E. Soldaini, S. Abrignani, and A. Wack
Coligation of the Hepatitis C Virus Receptor CD81 with CD28 Primes Naive T Lymphocytes to Acquire Type 2 Effector Function
J. Immunol.,
July 1, 2008;
181(1):
174 - 185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu and C. Rohowsky-Kochan
Regulation of IL-17 in Human CCR6+ Effector Memory T Cells
J. Immunol.,
June 15, 2008;
180(12):
7948 - 7957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Grant, U. Oh, K. Yao, Y. Yamano, and S. Jacobson
Dysregulation of TGF-{beta} signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease
Blood,
June 15, 2008;
111(12):
5601 - 5609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sauer, L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z. A. Knight, B. S. Cobb, D. Cantrell, E. O'Connor, et al.
T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR
PNAS,
June 3, 2008;
105(22):
7797 - 7802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Fox, P. A. Bignone, P. J. Brown, and A. H. Banham
Defense of the clone: antibody 259D effectively labels human FOXP3 in a variety of applications
Blood,
April 1, 2008;
111(7):
3897 - 3899.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Passerini, S. E. Allan, M. Battaglia, S. Di Nunzio, A. N. Alstad, M. K. Levings, M. G. Roncarolo, and R. Bacchetta
STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells
Int. Immunol.,
March 1, 2008;
20(3):
421 - 431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Ndhlovu, C. P. Loo, G. Spotts, D. F. Nixon, and F. M. Hecht
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection
J. Leukoc. Biol.,
February 1, 2008;
83(2):
254 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Das and A. D. Levine
TGF-{beta} Inhibits IL-2 Production and Promotes Cell Cycle Arrest in TCR-Activated Effector/Memory T Cells in the Presence of Sustained TCR Signal Transduction
J. Immunol.,
February 1, 2008;
180(3):
1490 - 1498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Pillai and N. J. Karandikar
Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity
Blood,
January 1, 2008;
111(1):
463 - 464.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Q. Tran and E. M. Shevach
Response: Anti human FOXP3 mAb PCH101 stains activated human naive T cells nonspecifically
Blood,
January 1, 2008;
111(1):
464 - 466.
[Full Text]
[PDF]
|
 |
|
| |